Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT03414970Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Lobular Breast Carcinoma | Ductal Breast Carcinoma | Tubular Breast Carcinoma | Medullary Breast Carcinoma
-
NCT01785069TerminatedBreast Augmentation | Breast Reconstruction | Breast Implant Revision
-
NCT01870869TerminatedBreast Augmentation | Breast Reconstruction | Breast Implant Revision
-
NCT04360941RecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Recurrent Breast Cancer | ER+ Breast Cancer
-
NCT04030507RecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast
-
NCT06388122RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Metastatic Breast Cancer | Anatomic Stage IV Breast Cancer AJCC v8 | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Metastatic Breast Carcinoma | HER2 Negative Breast Carcinoma | Hormone-receptor-positive Breast Cancer
-
NCT06678269RecruitingBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IV | Stage IV Breast Cancer | Breast Cancer Metastatic | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | Hormone-receptor-positive Breast Cancer
-
NCT04553770RecruitingInvasive Breast Cancer | Stage II Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Early-stage Breast Cancer | Stage III Breast Cancer
-
NCT00343109CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer
-
NCT01051401TerminatedStage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Cardiovascular Complications
-
NCT01483196CompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Cognitive/Functional Effects | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
-
NCT01824836Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Musculoskeletal Complications
-
NCT06774027RecruitingMetastatic Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | Metastatic Triple Negative Breast Cancers | HR+ HER2 Breast Cancer
-
NCT00368875CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer
-
NCT07186491Not yet recruitingBreast Cancer | Breast Asymmetry | Breast Abnormalities | Breast Lesion
-
NCT05501704RecruitingMale Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Negative Breast Carcinoma
-
NCT00096434CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT05233696WithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | PD-L1 Gene Mutation
-
NCT03184558TerminatedTriple Negative Breast Cancer | Inflammatory Breast Cancer Stage IV
-
NCT01084057CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT02225470CompletedBreast Cancer | Breast Tumors | Triple Negative Breast Cancer | Cancer of Breast | HER2-Negative Breast Cancer
-
-
NCT00244881CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00068588CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT01208441TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer
-
NCT00045188CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT00095888TerminatedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer
-
NCT05452213RecruitingBreast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer
-
NCT07201389Active, not recruitingBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast - Female | Chemotherapy Induced Alopecia
-
NCT01869764CompletedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in Situ
-
NCT01100489WithdrawnStage I Breast Cancer | HER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Ductal Breast Carcinoma in Situ
-
NCT06532812RecruitingBreast Cancer | Breast Carcinoma | Breast Cancer Metastatic | Breast Cancer Triple Negative
-
-
NCT06507930RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Unresectable Breast Carcinoma
-
NCT02338167RecruitingAdvanced/Metastatic Breast Cancer | Breast Cancer (Early Breast Cancer)
-
NCT07498400Active, not recruitingBreast Cancer | Breast Cancer (Triple Negative Breast Cancer (TNBC))
-
NCT03007979CompletedBreast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast
-
NCT02649283UnknownBreast Asymmetry Between Native Breast and Reconstructed Breast
-
NCT07188246RecruitingBreast Cancer | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Invasive | Breast Cancer Triple Negative
-
NCT06274736CompletedBreast Augmentation | Breast Reconstruction | Mammaplasty | Breast Implant; Complications | Breast Implantation; Methods, Safety and Performance
-
NCT06649331RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC)
-
NCT06087120RecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Stage III Breast Cancer
-
NCT04901299WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast Cancer
-
NCT00119262CompletedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer
-
NCT05584644CompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Breast Carcinoma | Cancer of Breast
-
NCT07447414RecruitingBreast Cancer | Breast Cancer (Early Breast Cancer)
-
NCT02891681CompletedBreast Cancer | Breast Tumors | Cancer of Breast | Malignant Neoplasm of Breast | Cancer of the Breast
-
NCT04296942TerminatedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative Breast Cancer | HER2+ Breast Cancer
-
NCT05677802RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Hormone Receptor-Negative Breast Carcinoma
-
NCT01238133TerminatedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma
-
NCT05795101RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast Adenocarcinoma
-
NCT04052555Active, not recruitingRecurrent Breast Carcinoma | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Bilateral Breast Carcinoma | Localized Breast Carcinoma